123 related articles for article (PubMed ID: 38403883)
1. Cancer stem cell biomarkers SOX2 and Oct4 in cervical cancer patients undergoing chemoradiotherapy.
Chakrabarti D; Qayoom S; Srivastava K; Resu AV; Kukreja D; Goel MM; Singh US; Akhtar N; Rajan S; Verma M; Gupta R; Bhatt MLB
Asia Pac J Clin Oncol; 2024 Jun; 20(3):407-415. PubMed ID: 38403883
[TBL] [Abstract][Full Text] [Related]
2. Association of OCT4, SOX2, and NANOG expression with oral squamous cell carcinoma progression.
Fu TY; Hsieh IC; Cheng JT; Tsai MH; Hou YY; Lee JH; Liou HH; Huang SF; Chen HC; Yen LM; Tseng HH; Ger LP
J Oral Pathol Med; 2016 Feb; 45(2):89-95. PubMed ID: 26211876
[TBL] [Abstract][Full Text] [Related]
3. Embryonic stem cell markers Sox-2 and OCT4 expression and their correlation with WNT signal pathway in cervical squamous cell carcinoma.
Ji J; Wei X; Wang Y
Int J Clin Exp Pathol; 2014; 7(5):2470-6. PubMed ID: 24966958
[TBL] [Abstract][Full Text] [Related]
4. High Expression of SOX2 and OCT4 Indicates Radiation Resistance and an Independent Negative Prognosis in Cervical Squamous Cell Carcinoma.
Shen L; Huang X; Xie X; Su J; Yuan J; Chen X
J Histochem Cytochem; 2014 Jul; 62(7):499-509. PubMed ID: 24710660
[TBL] [Abstract][Full Text] [Related]
5. Correlation of Cancer Stem-Cell Markers OCT4, SOX2, and NANOG with Clinicopathological Features and Prognosis in Operative Patients with Rectal Cancer.
You L; Guo X; Huang Y
Yonsei Med J; 2018 Jan; 59(1):35-42. PubMed ID: 29214774
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of OCT4 and SOX2 protein expression in cervical cancer.
Kim BW; Cho H; Choi CH; Ylaya K; Chung JY; Kim JH; Hewitt SM
BMC Cancer; 2015 Dec; 15():1015. PubMed ID: 26706028
[TBL] [Abstract][Full Text] [Related]
7. Lin28B/Let-7 Regulates Expression of Oct4 and Sox2 and Reprograms Oral Squamous Cell Carcinoma Cells to a Stem-like State.
Chien CS; Wang ML; Chu PY; Chang YL; Liu WH; Yu CC; Lan YT; Huang PI; Lee YY; Chen YW; Lo WL; Chiou SH
Cancer Res; 2015 Jun; 75(12):2553-65. PubMed ID: 25858147
[TBL] [Abstract][Full Text] [Related]
8. Putative stem cell markers in cervical squamous cell carcinoma are correlated with poor clinical outcome.
Hou T; Zhang W; Tong C; Kazobinka G; Huang X; Huang Y; Zhang Y
BMC Cancer; 2015 Oct; 15():785. PubMed ID: 26499463
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of Oct4 and Sox2 expression in hypopharyngeal squamous cell carcinoma.
Ge N; Lin HX; Xiao XS; Guo L; Xu HM; Wang X; Jin T; Cai XY; Liang Y; Hu WH; Kang T
J Transl Med; 2010 Oct; 8():94. PubMed ID: 20937145
[TBL] [Abstract][Full Text] [Related]
10. Low P16
Fu HC; Chuang IC; Yang YC; Chuang PC; Lin H; Ou YC; Chang Chien CC; Huang HS; Kang HY
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30150594
[TBL] [Abstract][Full Text] [Related]
11. The Prognostic Value of Cancer Stem Cell Markers in Cervical Cancer: A Systematic Review and Meta-Analysis.
Fahmi MN; Hertapanndika IN; Kusuma F
Asian Pac J Cancer Prev; 2021 Dec; 22(12):4057-4065. PubMed ID: 34967589
[TBL] [Abstract][Full Text] [Related]
12. OCT4 but not SOX2 expression correlates with worse prognosis in surgical patients with triple-negative breast cancer.
Zhang JM; Wei K; Jiang M
Breast Cancer; 2018 Jul; 25(4):447-455. PubMed ID: 29536377
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.
Bourguignon LY; Wong G; Earle C; Chen L
J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005
[TBL] [Abstract][Full Text] [Related]
14. Relative Expression of OCT4, SOX2 and NANOG in Oral Squamous Cell Carcinoma Versus Adjacent Non- Tumor Tissue.
Baghai Naini F; Aminishakib P; Abdollahi A; Hodjat M; Mohammadpour H; Kardouni Khoozestani N
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1649-1654. PubMed ID: 31244283
[TBL] [Abstract][Full Text] [Related]
15. Putative stemness markers octamer-binding transcription factor 4, sex-determining region Y-box 2, and NANOG in non-small cell lung carcinoma: A clinicopathological association.
Upadhyay VA; Shah KA; Makwana DP; Raval AP; Shah FD; Rawal RM
J Cancer Res Ther; 2020; 16(4):804-810. PubMed ID: 32930122
[TBL] [Abstract][Full Text] [Related]
16. Prognostic evaluation of Nanog, Oct4, Sox2, PCNA, Ki67 and E-cadherin expression in gastric cancer.
Li N; Deng W; Ma J; Wei B; Guo K; Shen W; Zhang Y; Luo S
Med Oncol; 2015 Jan; 32(1):433. PubMed ID: 25491144
[TBL] [Abstract][Full Text] [Related]
17. Expression of Sox2 and Oct4 and their clinical significance in human non-small-cell lung cancer.
Li X; Wang J; Xu Z; Ahmad A; Li E; Wang Y; Qin S; Wang Q
Int J Mol Sci; 2012; 13(6):7663-7675. PubMed ID: 22837720
[TBL] [Abstract][Full Text] [Related]
18. [Expression of Oct4 and Sox2 and their clinical significance in tongue squamous cell carcinoma].
Jiang XD; Luo G; Wang XH; Chen LL; Ke X; Li Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2017 Jan; 52(1):27-33. PubMed ID: 28072991
[No Abstract] [Full Text] [Related]
19. Association of SOX2, OCT4 and WNT5A Expression in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma: An Immunohistochemical Study.
Vijayakumar G; Narwal A; Kamboj M; Sen R
Head Neck Pathol; 2020 Sep; 14(3):749-757. PubMed ID: 31902091
[TBL] [Abstract][Full Text] [Related]
20. Correlation of ALDH1, CD44, OCT4 and SOX2 in tongue squamous cell carcinoma and their association with disease progression and prognosis.
Huang CF; Xu XR; Wu TF; Sun ZJ; Zhang WF
J Oral Pathol Med; 2014 Aug; 43(7):492-8. PubMed ID: 24450601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
